» Articles » PMID: 9247299

Differential Inhibitory Effect of L-lysine on Renal Accumulation of 67Cu-labelled F(ab')2 Fragments in Mice

Overview
Journal Int J Cancer
Specialty Oncology
Date 1997 Jul 29
PMID 9247299
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The basic amino acid L-lysine was administered to mice in an attempt to circumvent unwanted renal accumulation of 67Cu-labelled F(ab')2 fragments derived from the anti-NCAM IgG1, SEN7 and anti-CEA IgG1 monoclonal antibody (MAb)35. In control experiments, significant renal uptake of both 67Cu-labelled F(ab')2 fragments was observed, radiolabel being primarily localised to proximal tubules in the renal cortex. Following optimised L-lysine dosing protocols, renal uptake of 67Cu-MAb35 F(ab')2 was inhibited by up to 42%. Surprisingly, little inhibition (< 10%) of 67Cu-SEN7 F(ab')2 uptake was observed. Experiments to investigate this differential inhibition indicated that inhibition of MAb35 F(ab')2 uptake was relatively short-lived (approx. 6 hr), whilst no apparent differences were found in blood clearance rates between either 67Cu-F(ab')2 fragment. L-lysine administration caused a significant diuresis with high levels of intact 67Cu-labelled SEN7 and MAb35 F(ab')2 appearing in the urine, possibly due to blockade of renal uptake and lysine-induced increases in glomerular membrane permeability. Iso-electric focusing studies failed to identify any charge differences between the 67Cu-labelled F(ab')2 fragments, although a cathodal migration of all 67Cu-labelled samples, presumably due to the net positive charge conferred by addition of 67Cu2+ ions, was observed. Our results demonstrate that in addition to net charge, other unidentified characteristics may influence renal accumulation of radiometal-labelled F(ab')2 fragments and their inhibition by L-lysine.

Citing Articles

Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct.

Kelly M, Lee F, Tahtis K, Power B, Smyth F, Brechbiel M Cancer Biother Radiopharm. 2008; 23(4):411-23.

PMID: 18771345 PMC: 2663784. DOI: 10.1089/cbr.2007.0450.